Drug recall · January 1, 2014
Dexedrine¿ recall
Why: Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dexedrine¿ (Dextroamphetamine Sulfate) Spansules¿ Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by Catalent Pharma Solutions Winchester, KY 40391 for Amedra Pharmaceuticals, LLC Middlesex, NJ 08846, NDC 52054-514-09
- Lots / codes
Lot# 243459; Exp. 01/14
- Quantity
- 10,992 bottles
- Company
- Amedra Pharmaceuticals LLC, Horsham, PA
- Distribution
- Nationwide
- Initiated
- October 7, 2013 · Voluntary: Firm initiated
- Classified
- December 23, 2013
- Reported
- January 1, 2014
- Ended
- October 7, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dextroamphetamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.